Skip to main content

Li Yishan's Form 4 filing

BlossomHill Therapeutics, Inc. (BLSM) · filed Aug 10, 2026

Accession no.
0001772233-26-000005
Filed
Aug 10, 2026, 6:23 PM ET
Trade date
Aug 6-10, 2026
Filing delay
4 days
Rule 10b5-1 plan
Not checked

This filing lists 3 non-derivative transactions and 4 derivative transactions. It was filed 4 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Li YishanCIK 0001772233Director, Officer (Executive Chairman), 10% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Aug 10, 2026Common StockCConversionAcquired+1,600,682––1,600,682IndirectDuplicate filing
Aug 10, 2026Common StockCConversionAcquired+113,435––1,714,117IndirectDuplicate filing
Aug 10, 2026Common StockCConversionAcquired+124,779––124,779IndirectDuplicate filing

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Aug 6, 2026Common StockAGrant or awardAcquired+112,701$0.00$0112,701Direct
Aug 10, 2026Common StockCConversionDisposed−1,600,682––0IndirectDuplicate filing
Aug 10, 2026Common StockCConversionDisposed−113,435––0IndirectDuplicate filing
Aug 10, 2026Common StockCConversionDisposed−124,779––0IndirectDuplicate filing

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)